Atripla approval in Europe.
D000225:Adenine / Q000031:analogs & derivatives*; D000480:Alkynes; D000998:Antiviral Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D017277:Drug Approval; D000068679:Emtricitabine; D005060:Europe; D063065:Organophosphonates; D010078:Oxazines; D000068698:Tenofovir
D000480:Alkynes; D000998:Antiviral Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D063065:Organophosphonates; D010078:Oxazines; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine; C098320:efavirenz